Rang	Name	Position
1	Mr. Randal J. Kirk J.D.	Executive Chairman
2	Dr. Helen Sabzevari MPH, Ph.D.	President, CEO & Director
3	Mr. Harry Thomasian Jr.	Chief Financial Officer
4	Mr. Rutul R. Shah	Chief Operating Officer
5	Mr. Donald P. Lehr J.D., Ph.D.	Chief Legal Officer & Corporate Secretary
6	Mr. Phil Tennant	Chief Commercial Officer
7	Mr. Steven M. Harasym	VP & Head of Investor Relations
8	Dr. Douglas E. Brough Ph.D.	Senior VP & Head of Research
9	Dr. Bryan T. Butman Ph.D.	Senior VP & Head of CMC
10	Dr. Amy R. Lankford Ph.D.	Senior VP & Head of Clinical Operations and Regulatory Affairs

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	Patients Capital Management LLC	5,32%	0,15 Mrd. USD
2	BlackRock Inc	4,79%	0,13 Mrd. USD
3	State Street Corp	3,35%	0,09 Mrd. USD
4	Diametric Capital, LP	2,59%	0,07 Mrd. USD
5	Vanguard Capital Management, LLC	2,21%	0,06 Mrd. USD
6	TANG CAPITAL MANAGEMENT LLC	1,79%	0,05 Mrd. USD
7	Boxer Capital Management, LLC	1,44%	0,04 Mrd. USD
8	Geode Capital Management, LLC	1,40%	0,04 Mrd. USD
9	Iridian Asset Management LLC	1,13%	0,03 Mrd. USD
10	Occam Crest Management L.P.	1,01%	0,03 Mrd. USD
11	Morgan Stanley - Brokerage Accounts	0,97%	0,03 Mrd. USD
12	The Goldman Sachs Group Inc	0,95%	0,03 Mrd. USD
13	FMR Inc	0,72%	0,02 Mrd. USD
14	Vanguard Portfolio Management, LLC	0,62%	0,02 Mrd. USD
15	First Trust Advisors L.P.	0,56%	0,02 Mrd. USD
16	Bank of America Corp	0,52%	0,01 Mrd. USD
17	Arrowstreet Capital Limited Partnership	0,50%	0,01 Mrd. USD
18	Northern Trust Corp	0,50%	0,01 Mrd. USD
19	Charles Schwab Investment Management Inc	0,42%	0,01 Mrd. USD
20	Woodline Partners LP	0,39%	0,01 Mrd. USD